TherapeuticsMD, Inc. (TXMD) is listed on NASDAQ in the Manufacturing sector. This page tracks real-time TXMD price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
RSI (14) 59.3 Neutral
Market Cap $24.0M
Volume 14.6K
Fundamentals — 10-Q Q2 2026
Revenue --
Net Income $250,000
EPS $0.02
P/E Ratio 103.5x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Thompson Tommy G | Director | Buy | 8,400 | $1.67 | $14,028 | 2025 Dec 23 |
| Thompson Tommy G | Director | Buy | 325 | $1.00 | $325 | 2025 Apr 14 |
| Walker Marlan D | Chief Executive Officer | Buy | 490 | $1.00 | $490 | 2025 Apr 14 |
| Walker Marlan D | Chief Executive Officer | Buy | 2,303 | $0.86 | $1,992 | 2025 Apr 10 |
| Collins Cooper C. | Director | Buy | 4,094 | $1.73 | $7,083 | 2024 Aug 22 |
| Collins Cooper C. | Director | Buy | 1,200 | $1.70 | $2,040 | 2024 Aug 21 |
| Walker Marlan D | Chief Executive Officer | Sell | 19,050 | $2.29 | $43,687 | 2023 Dec 7 |
| Walker Marlan D | Chief Executive Officer | Sell | 1,170 | $3.65 | $4,271 | 2023 Apr 12 |
| Donegan Michael C | Prin. Fin. and Acctg. Officer | Sell | 1,697 | $5.08 | $8,621 | 2023 Jan 27 |
| Donegan Michael C | Prin. Fin. and Acctg. Officer | Sell | 1,309 | $5.34 | $6,990 | 2023 Jan 24 |
| Rosen David Efraim | 10% Owner | Sell | 29,000 | $1333.00 | $38.7M | 2022 Dec 30 |
| Rosen David Efraim | 10% Owner | Buy | 14,825 | $6.09 | $90,284 | 2022 Dec 9 |
| Bernick Brian | Co-Chief Executive Officer | Sell | 1,255 | $5.27 | $6,619 | 2022 Dec 9 |
| Rubric Capital Management LP | 10% Owner | Buy | 20,413 | $5.66 | $115,589 | 2022 Dec 8 |
| Naughton Gail K | Director | Sell | 3,922 | $5.26 | $20,630 | 2022 Dec 7 |
| Donegan Michael C | Interim CFO/CAO/VP of Finance | Sell | 910 | $4.78 | $4,350 | 2022 Dec 6 |
| Glickman Mark A | Co-Chief Executive Officer | Sell | 440 | $4.92 | $2,165 | 2022 Dec 6 |
| Walker Marlan D | General Counsel | Sell | 1,048 | $4.95 | $5,188 | 2022 Dec 6 |
| Rosen David Efraim | 10% Owner | Buy | 7,000 | $1000.00 | $7.0M | 2022 Oct 28 |
| Rosen David Efraim | 10% Owner | Buy | 7,000 | $1000.00 | $7.0M | 2022 Sep 30 |
Take TXMD further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put TXMD in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when TherapeuticsMD, Inc. next reports.
Set alerts on TXMD
Get notified when TherapeuticsMD, Inc. hits your price targets or technical conditions are met.
Get Started Free